SR-4835

SR-4835
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T8325-1mg 1 mg

7 - 10 business days*

52.00€
TGM-T8325-2mg 2 mg

7 - 10 business days*

74.00€
TGM-T8325-5mg 5 mg

7 - 10 business days*

120.00€
TGM-T8325-1mL 1 ml

7 - 10 business days*

133.00€
TGM-T8325-10mg 10 mg

7 - 10 business days*

198.00€
TGM-T8325-25mg 25 mg

7 - 10 business days*

408.00€
TGM-T8325-50mg 50 mg

7 - 10 business days*

594.00€
TGM-T8325-100mg 100 mg

7 - 10 business days*

864.00€
TGM-T8325-500mg 500 mg

7 - 10 business days*

1,772.00€
 
Description: SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM,... more
Product information "SR-4835"
Description: SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM, Kd=98 nM, CDK13: Kd=4.9 nM), which disables triple-negative breast cancer (TNBC) cells. Target: Apoptosis, CDK. Smiles: Cn1cc(cn1)-n1cnc2c(NCc3nc4cc(Cl)c(Cl)cc4[nH]3)nc(nc12)N1CCOCC1. References: Quereda V, et al. Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer. Cancer Cell. 2019 Oct 8. pii: S1535-6108(19)30424-6.
Supplier: TargetMol
Supplier-Nr: T8325

Properties

Application: Cdk12 / Cdk13 inhibitor
MW: 499.36 D
Formula: C21H20Cl2N10O

Database Information

CAS : 2387704-62-1| Matching products
KEGG ID : K08819 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "SR-4835"
Write a review
or to review a product.
Viewed